(Q39902254)
Statements
Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent manner (English)
Ana Catarina Pinto
1 reference
João Nuno Moreira
1 reference
Sérgio Simões
1 reference
23 December 2008
1 reference
1 reference
1 reference